Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.56 USD
Change Today +0.03 / 5.66%
Volume 1.3M
As of 8:04 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Timothy C. Scott Ph.D.

President, Director, President of Xantech and Director of Xantech, Provectus Biopharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Timothy C. Scott, also known as Tim, Ph.D. has been the President of Provectus Pharmaceuticals, Inc. since April 23, 2002. Dr. Scott serves as President of Xantech at Provectus Pharmaceuticals Inc. Dr. Scott served as the Chief Executive Officer, Interim President, Chief Operating Officer, Senior Scientist, Chief Financial Officer and Treasurer from February 2000 to May 2000. Prior to joining Provectus, Dr. Scott was as a senior member of the Photogen management ...

Read Full Background

Corporate Headquarters*

7327 Oak Ridge Highway
Knoxville, Tennessee 37931

United States

Phone: 866-594-5999
Fax: 866-998-0005

Board Members Memberships*

Former Chief Executive Officer, Interim President, Chief Financial Officer, Chief Operating Officer and Senior Scientist
President, Director, President of Xantech and Director of Xantech


PhD 1985
University of Wisconsin - Madison
The University of Tennessee

Other Affiliations*

Annual Compensation*

Total Annual Compensation$500,000

Stock Options*

All Other Compensation$137,692
Exercised Options548,236
Exercised Options Value$271,767
Exercisable Options3,051,764
Total Value of Options$271,767
Total Number of Options3,600,000

Total Compensation*

Total Annual Cash Compensation$637,692
Total Short Term Compensation$500,000
Other Long Term Compensation$137,692
Total Calculated Compensation$666,154
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PVCT:US $0.56 USD +0.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROVECTUS BIOPHARMACEUTICA-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at